Engineered herpes virus shows promise against advanced melanoma
New Scientist - 08-Jul-2025RP1 shrinks deep skin tumours and may soon win FDA approval as a new melanoma treatment
Join the club for FREE to access the whole archive and other member benefits.
Associate professor of clinical medicine at USC’s Keck School of Medicine
Dr. Gino K. In, MD, MPH, is an associate professor of clinical medicine at USC’s Keck School of Medicine and a specialist in medical and surgical oncology, with a focus on melanoma and other skin cancers. He completed his hematology/oncology fellowship at USC, where he also served as chief fellow, and is now based at the USC Norris Comprehensive Cancer Center. Dr. In leads clinical trials in cutaneous oncology and is actively involved in developing intratumoral therapies, including the promising RP1 and nivolumab combination for advanced melanoma.
Visit website: https://keck.usc.edu/faculty-search/gino-in/
See alsoDetails last updated 14-Jul-2025
RP1 shrinks deep skin tumours and may soon win FDA approval as a new melanoma treatment